BR112012005401A2 - agente terapêutico para a dor crônica - Google Patents

agente terapêutico para a dor crônica

Info

Publication number
BR112012005401A2
BR112012005401A2 BR112012005401A BR112012005401A BR112012005401A2 BR 112012005401 A2 BR112012005401 A2 BR 112012005401A2 BR 112012005401 A BR112012005401 A BR 112012005401A BR 112012005401 A BR112012005401 A BR 112012005401A BR 112012005401 A2 BR112012005401 A2 BR 112012005401A2
Authority
BR
Brazil
Prior art keywords
therapeutic agent
chronic pain
pain
chronic
therapeutic
Prior art date
Application number
BR112012005401A
Other languages
English (en)
Inventor
Mashiko Hirobumi
Otani Koji
Kasahara Satoshi
Niwa Shin-Ichi
Konno Shinichi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BR112012005401A2 publication Critical patent/BR112012005401A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
BR112012005401A 2009-09-11 2010-02-26 agente terapêutico para a dor crônica BR112012005401A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009211021 2009-09-11
PCT/JP2010/053032 WO2011030575A1 (ja) 2009-09-11 2010-02-26 慢性疼痛治療剤

Publications (1)

Publication Number Publication Date
BR112012005401A2 true BR112012005401A2 (pt) 2017-02-21

Family

ID=43732252

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012005401A BR112012005401A2 (pt) 2009-09-11 2010-02-26 agente terapêutico para a dor crônica

Country Status (16)

Country Link
US (1) US20120258971A1 (pt)
JP (2) JPWO2011030575A1 (pt)
KR (2) KR20160147061A (pt)
AU (1) AU2010293647B2 (pt)
BR (1) BR112012005401A2 (pt)
CA (1) CA2773253A1 (pt)
CO (1) CO6531434A2 (pt)
IL (1) IL218495A0 (pt)
MX (1) MX2012002952A (pt)
MY (1) MY162348A (pt)
NZ (1) NZ599227A (pt)
RU (1) RU2555760C2 (pt)
SG (1) SG178938A1 (pt)
TW (1) TWI465442B (pt)
UA (1) UA108862C2 (pt)
WO (1) WO2011030575A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
US20190117637A1 (en) * 2016-06-13 2019-04-25 Board Of Regents Of The University Of Texas System Pharmaceutical compositions and methods for treatment of pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130587A (en) 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2608788B2 (ja) * 1988-10-31 1997-05-14 大塚製薬 株式会社 精神分裂病治療剤
UA80802C2 (en) * 2001-09-25 2007-11-12 Low hygroscopic aripiprazole drug substance and process for the preparation thereof
JP2006514633A (ja) * 2002-11-26 2006-05-11 アレックザ ファーマシューティカルズ, インコーポレイテッド 吸入によって送達される抗精神病薬を用いた頭痛の治療
US20090198059A1 (en) * 2004-09-13 2009-08-06 Chava Satyanarayana Process for the preparation of polymorphs, solvates of aripiprazole using aripirazole acid salts

Also Published As

Publication number Publication date
TW201109312A (en) 2011-03-16
RU2555760C2 (ru) 2015-07-10
TWI465442B (zh) 2014-12-21
RU2012114097A (ru) 2013-10-20
MX2012002952A (es) 2012-04-02
KR20160147061A (ko) 2016-12-21
NZ599227A (en) 2014-02-28
SG178938A1 (en) 2012-04-27
IL218495A0 (en) 2012-07-31
WO2011030575A1 (ja) 2011-03-17
CA2773253A1 (en) 2011-03-17
AU2010293647A1 (en) 2012-03-29
AU2010293647B2 (en) 2015-06-25
JP2015129160A (ja) 2015-07-16
JP6025886B2 (ja) 2016-11-16
CO6531434A2 (es) 2012-09-28
MY162348A (en) 2017-06-15
KR20120065392A (ko) 2012-06-20
UA108862C2 (uk) 2015-06-25
US20120258971A1 (en) 2012-10-11
JPWO2011030575A1 (ja) 2013-02-04

Similar Documents

Publication Publication Date Title
HRP20181615T1 (hr) Terapijsko sredstvo koje izaziva citotoksičnost
BR112014009634A2 (pt) preparação e agente terapêutico
BRPI0915476A2 (pt) dispositivo para tratar problemas respiratórios
BRPI0821145A2 (pt) Agente terapêutico para prurido
ATE526024T1 (de) Fluvoxamin vermeidende pirfenidontheraphy
BRPI1014628A2 (pt) cateter de injeção para enviar um agente terapêutico a um substrato
BR112013011874A2 (pt) compostos e métodos para tratar dor
BRPI0819630A2 (pt) Montagem de interface de paciente para terapia respiratória
BR112012031836A2 (pt) combinação farmacêutica para o tratamento da dor
BR112012001819A2 (pt) métodos para tratamento de dor
BR112012000502A2 (pt) terapia de combinação para o tratamento de diabetes
BRPI1008598A2 (pt) composição farmacêutica para inalação
BRPI1008664A2 (pt) comprimidos para a terapia de combinação
BRDI7106622S (pt) Configuração aplicada em remédio para alívio de dor
BR112012009021A2 (pt) dispositivo de cuidados para tecidos
BRPI0906606A2 (pt) Tratamento terapêutico para condições do pulmão.
BRPI0818598A2 (pt) agentes terapêuticos - 802
SMT201600041B (it) Agenti terapeutici 713
EP2554163A4 (en) THERAPEUTIC ACTIVE FOR NEURODEGENERATIVE DISEASES
BR112015010428A2 (pt) agente terapêutico para distúrbios ceratoconjuntivos
ZA201301458B (en) Therapeutic agent for pain
EP2601954A4 (en) THERAPEUTIC FOR DISEASES
BRPI1013903A2 (pt) tratamentos terapêuticos utilizando centaquina
GB0900484D0 (en) Therapeutic agent
BR112012013591A2 (pt) dispositivo para tratamento eletroterapêutico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2503 DE 26/12/2018.